Article Information
History
- September 10, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 10, 2020 - 03:33).
- Version 2 (December 7, 2020 - 07:42).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kate M. Bubar1,2,*,
- Stephen M. Kissler3,
- Marc Lipsitch3,4,
- Sarah Cobey5,
- Yonatan H. Grad3 and
- Daniel B. Larremore6,7,*
- 1Department of Applied Mathematics, University of Colorado Boulder, Boulder, CO, 80303, USA
- 2IQ Biology Program, University of Colorado Boulder, Boulder, CO, 80309, USA
- 3Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
- 4Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
- 5Department of Ecology and Evolution, University of Chicago, Chicago, IL, 60637, USA
- 6Department of Computer Science, University of Colorado Boulder, Boulder, CO, 80309, USA
- 7BioFrontiers Institute, University of Colorado Boulder, Boulder, CO, 80303, USA
- ↵*To whom correspondence should be addressed; E-mail: kate.bubar{at}colorado.edu and daniel.larremore{at}colorado.edu
Posted September 10, 2020.
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
